Letermovir prophylaxis and early CMV DNAemia after allogeneic hematopoietic stem cell transplantation: a real‑world study from China
Abstract Letermovir is a cytomegalovirus (CMV) prophylactic agent that is not associated with clinically significant myelosuppression. However, real-world data regarding its clinical use in Chinese allogeneic hematopoietic stem cell transplantation (allo-HSCT) remain limited. This study aimed to ass...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Nature Portfolio
2026-04-01
|
| Saila: | Scientific Reports |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1038/s41598-026-50851-1 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|